Dr. Nicole Bradley, PhD, is Senior Scientist for Rejenevie™ Therapeutics where she is expanding the company’s core stem cell restoration technology and supporting clinical development of Rejenevie’s lead cell therapy product. Dr. Bradley will perform highly skilled hematopoietic stem cell and cellular immunology techniques, including becoming proficient in the company’s proprietary cell culture technology to restore aging stem and immune cell function.
Dr. Bradley received her Bachelor’s degree in Medical Microbiology from the University of California, Davis in 2010. She completed her Ph.D. in Integrative Pathobiology at the University of California, Davis in 2015, where she focused on immunological responses to vaccine components, and modulation of the immune system through modulation of T-cells and their responses. Following graduation, Dr. Bradley continued on to become a postdoctoral fellow at the University of Arizona, College of Medicine, Departments of Immunobiology and Infectious Disease. At the Department of Immunobiology, she has been working to determine the viral, immunological, and genetic factors associated with aging and HIV-1 infection in HIV-infected older patients on prolonged ART. Additionally, at the Department of Infectious Disease, Dr. Bradley has worked on numerous projects including, determination of carriage rates of Chagas Disease in Kissing Bugs and transmission rates to human hosts across Southern Arizona, along with studying Candida albicans infection and its ability to evade host detection leading to systemic disease.